Use of taci as an anti-tumor agent

Details for Australian Patent Application No. 2001253920 (hide)

Owner Biogen, Inc. Apoxis SA

Inventors Ambrose, Christine; Schneider, Pascal; Thompson, Jeffrey; Rennert, Paul

Agent Watermark

Pub. Number AU-B-2001253920

PCT Pub. Number WO01/81417

Priority 60199946 27.04.00 US

Filing date 27 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 16 March 2006

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 March 2006 Application Accepted

  Published as AU-B-2001253920

28 September 2006 Standard Patent Sealed

13 September 2007 Change of Name(s) of Applicant(s), Section 104

  Apoxis SA; Biogen, Inc. The name of the applicant has been changed to Apoxis SA; Biogen Idec MA Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253921

2001253919-Administration of a thiol-based chemoprotectant compound